Apparent higher frequency of phenylketonuria in the Mexican state of Jalisco

Human Genetics

Volumn 97, Issue 1, 1996, Pages 99-102

  Velázquez, Antonio ^a   Bilbao, Guadalupe ^b   González Trujillo, José Luis ^b   Hernández, Doris ^a   Pérez Andrade, Martha E ^a   Vela, Marcela ^a   Cicerón, Isabel ^a   Loera Luna, Antonio ^c   Cederbaum, Stephen ^d   Phoenix, Betsy ^d  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; MENTAL DEFICIENCY; MEXICO; NEWBORN SCREENING; PHENYLKETONURIA; PRIORITY JOURNAL; UNITED STATES;

CHILD; DEMOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MENTAL RETARDATION; METABOLIC DISEASES; MEXICO; PHENYLKETONURIAS; PROSPECTIVE STUDIES;

EID: 13344282088     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Alvarez JR (1977) Lagos de Moreno, Jalisco. In: Enciclopedia de México, vol. 7, Mexico City, pp 1150-1162
2. Eisensmith RC, Okano Y, Dasovich M, Wang T, et al. (1992) Multiple origins for phenylketonuria in Europe. Am J Hum Genet 51:1355-1365
3. Guthrie R, Susi A (1963) A simple phenylalanine method for detectine phenylketonuria in large population of newborn infants. Pediatrics 32:338-343
4. Güttler F, Lou H (1990) Phenylketonuria and hyperphenylalaninemia. In: Fernandes J, Saudubray J-M, Tada K (eds) Inborn metabolic diseases. Springer, Berlin Heidelberg, pp 161-174
5. Márquez-Morfín L (1993) La evolución cuantitativa de la población novohispana siglos XVI al XVII. In: El poblamiento de México, vol. 2: El México colonial. Secretaría de Gobernación, Consejo Nacional de Población, Mexico City. pp 36-63
6. McCaman MW, Robins E (1962) Fluorimetric method for determination of phenylalanine in serum. J Lab Clin Med 59: 885-889
7. Moya-Benabert M, Cortes-Castele E, Alvarez-Arenas JMR, et al. (1994) Neonatal screening in Spain 1968-1992. In: Farriaux JP, Dhondt JL (eds) New horizons in neonatal screening. Excerpta Medica, Amsterdam, pp 317-324
8. Pérez B, Desviat LR, Die M, et al. (1993) Presence of the Mediterranean PKU mutation IVS10 in Latin America. Hum Mol Genel 2:1289-1290
9. Roesel RA, Blankenship PR, Hommes FA (1986) HPLC assay of phenylalanine and tyrosine in blood spots on filter paper. Clin Chim Acta 156:91-96
10. Saénz-Faulhaber ML (1993) El mestizaje en la integración de la población colonial. In: Arenzana A (ed) El poblamiento de México, vol 2: El México colonial. Secretaría de Gobernación, Consejo Nacional de Población, Mexico City, pp 86-107
11. Shaw KNF, Gutenstein M, Jacobs EE, Blaskovics JC (1968) Biochemical screening and monitoring of patients with phenylketonurian and variant forms of hyperphenylalaninemia. In: Bickel H, Hudson F, Woolf L (eds) Phenylketonuria. Thieme, Stuttgart, pp 163-180
12. Thalhammer O (1975) Frequency of inborn errors of metabolism, especially PKU. in some representative newborn screening centers around the world. Humangenetik 30:273-282
13. Thomas G, Howell R (1973) Selected screening tests for genetic metabolic diseases. Year Book Medical Publishers. Chicago, pp 19-25